Mode
Text Size
Log in / Sign up
N/A Completed N=45 Randomized Prevention

Impact of Sleep Restriction on Performance in Adults

Sleep · Obesity · Sleep Restriction
Source: ClinicalTrials.gov NCT02960776 ↗
Enrolled (actual)
45
Serious AEs
0.0%
Results posted
Jul 2024
Primary outcomePrimary: Endpoint Fat Volume — 24.0; 24.2 Liter

Summary

The overall goal of this project is to look at the effects of long-term, sustained sleep restriction (SR) in adults, and assess the effects on mood and cognitive and physical performance.

Outcome Measures

OutcomeResultp-value
PRIMARY
Endpoint Fat Volume
24.0; 24.2
SECONDARY
Energy Expenditure (EE)
2445; 2476
SECONDARY
Physical Activity
86.1; 87.4
SECONDARY
Ghrelin
856.6; 819.4
SECONDARY
Regional Brain Activation in Response to Food Stimuli
469; 218
SECONDARY
Sedentary Behavior
766.9; 851
SECONDARY
Leptin
23.4; 23.5
SECONDARY
Glucagon-like Peptide 1
22.9; 23.0
SECONDARY
Orexin
1.29; 1.34
SECONDARY
Neuropeptide Y
1.36; 1.41

Eligibility Criteria

Inclusion Criteria

  • BMI 25-29.9 kg/m2
  • Have at least one obese parent
  • Habitually sleep 7-9 hours a night
  • Free of any current and past sleep and psychiatric disorders, including eating disorders, diabetes or Cardiovascular disease (CVD) (i.e., normal scores on: Pittsburgh Quality of Sleep Questionnaire Epworth Sleepiness Scale, Berlin Questionnaire, Sleep Disorders Inventory Questionnaire, Beck Depression Inventory, Composite Scale of Morningness/Eveningness, Three Factor Eating Questionnaire)
  • All racial/ethnic groups

Exclusion Criteria

  • Smokers (any cigarettes or ex-smoker 300 mg/d
  • Heavy equipment operators
  • Commercial long-distance drivers
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02960776). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search